NOD.Cg-Mcph1^{Tg(HLA-A2.1)1Enge} Prkdc^scid/Dvs

Stock number: 004262
Product name: NOD-scid-HLA-A2
Research areas: Immunology, Inflammation and Autoimmunity Research, Internal/Organ Research, Research Tools, Virology Research

Detailed description

This strain was developed to provide humanized islet allograft donors. NOD-scid-HLA-A2 positive islet grafts in diabetic NOD-RagI^nullPrf1^null mice are rejected by HLA-A2-negative, but not by HLA-A2-positive, human peripheral blood mononuclear cells. Graft rejection occurred in the absence of detectable graft-vs-host disease (GVHD). This strain is useful as a model for the in vivo study of human islet allograft rejection.

Development

NOD.CB17-Prkdc^scid was crossed once with NOD.B6-TgN(HLA-A2.1)1Enge/Dvs (Stock #003088) and the doubly heterozygous offspring were backcrossed once to NOD.CB17-Prkdc^scid to make the strain homozygous for Prkdc^scid then sibling mated to fix the strain homozygous for TgN(HLA-A2.1)1Enge as well.

Allele

Symbol: Prkdc^scid
Name: severe combined immunodeficiency
MGI accession ID: MGI:1857113
Generation method: Spontaneous
Marker symbol: Prkdc
Marker name: protein kinase, DNA activated, catalytic polypeptide
Chromosome: 16
Strain of origin: C.BKa-Igh^b/Icr
Site of expression: T and B lymphocytes.
Molecular note: A T-to-A transversion point mutation at a position corresponding to codon 4046 (codon 4095 in transcript ENSMUST00000023352.8) created a premature stop codon (p.Y4046*).

Allele

Symbol: Mcph1^{Tg(HLA-A2.1)1Enge}
Name: transgene insertion 1, Victor H Engelhard
MGI accession ID: MGI:3056375
Generation method: Transgenic
Attributes: Null/Knockout; Inserted expressed sequence; Humanized sequence
Marker symbol: Mcph1
Marker name: microcephaly, primary autosomal recessive 1
Chromosome: 8
Strain of origin: C57BL/6
Expressed genes: HLA-A,major histocompatibility complex, class I, A,human
Molecular note: The transgene contains the full length HLA-A2.1 gene. Expression of human class I MHC Ag HLA-A2.1 was detected on cells from homozygous transgenic spleen, bone marrow, and thymus. Line 1 inserted into the gene at 18736683-18757058 (Build GRCm38/mm10) resulting in a duplication. The duplication results in a functional knock-out. Founder line 1 has a copy number of 3-8.
General note: Expression of this human class I molecule in transgenic mice does not result in expansion of the number of cytotoxic T lymphocyte (CTL) precursors specific for other human class I Ag, HLA-B27 or HLA-A2.2.